2,935 followers
Take a look at this great #internalmedicine title: Treatment of Inflammatory Bowel Disease with Biologics https://t.co/aVveMf9vjp
Treatment of Inflammatory Bowel Disease with Biologics
Overview of attention for book
Table of Contents
-
Altmetric BadgeBook Overview
-
Altmetric BadgeChapter 1 Mechanism of Action and Pharmacokinetics of Biologics
-
Altmetric BadgeChapter 2 Antitumor Necrosis Factor Agents in Ulcerative Colitis
-
Altmetric BadgeChapter 3 Antitumor Necrosis Factor Agents in Crohn’s Disease
-
Altmetric BadgeChapter 4 Anti-TNF Therapy for Treatment of Extraintestinal Manifestations of Inflammatory Bowel Disease
-
Altmetric BadgeChapter 5 Use of Biologics in the Postoperative Management of Crohn’s Disease
-
Altmetric BadgeChapter 6 Biologics in Pregnancy and Breastfeeding
-
Altmetric BadgeChapter 7 Concomitant Use of Immunosuppressive Therapy with Tumor Necrosis Factor (TNF) Antagonists in Inflammatory Bowel Disease
-
Altmetric BadgeChapter 8 Therapeutic Drug Monitoring of Biologic Agents
-
Altmetric BadgeChapter 9 Use of Biologics in Crohn’s Disease and Ulcerative Colitis Prior to Surgery and Perioperative Risks
-
Altmetric BadgeChapter 10 Cessation of Biologics: Can It Be Done?
-
Altmetric BadgeChapter 11 Biologic Therapy in Pediatric Inflammatory Bowel Disease
-
Altmetric BadgeChapter 12 Infectious Complications of Biologics
-
Altmetric BadgeChapter 13 Tumor Necrosis Factor-Alpha Inhibitors and Risks of Malignancy
-
Altmetric BadgeChapter 14 Noninfectious and Nonmalignant Complications of Anti-TNF Therapy
-
Altmetric BadgeChapter 15 Biosimilars in Inflammatory Bowel Disease 2017: State of the Science, State of the Art, and State of the Finances
-
Altmetric BadgeChapter 16 Anti-integrin Agents in IBD: Efficacy and Risk of Complications
-
Altmetric BadgeChapter 17 Novel Agents in Inflammatory Bowel Disease
-
Altmetric BadgeChapter 18 Quality, Safety, and Practical Considerations of Using Biologic Therapies